119 related articles for article (PubMed ID: 7590773)
1. p53 trans-dominantly suppresses tumor formation of human breast cancer cells mediated by retroviral bulk infection without marker gene selection: an expeditious in vitro protocol with implications towards gene therapy.
Runnebaum IB; Kreienberg R
Hybridoma; 1995 Apr; 14(2):153-7. PubMed ID: 7590773
[TBL] [Abstract][Full Text] [Related]
2. Wild-type p53 suppresses the malignant phenotype in breast cancer cells containing mutant p53 alleles.
Runnebaum IB; Yee JK; Kieback DG; Sukumar S; Friedmann T
Anticancer Res; 1994; 14(3A):1137-44. PubMed ID: 8074464
[TBL] [Abstract][Full Text] [Related]
3. Molecular therapy with recombinant p53 adenovirus in an androgen-independent, metastatic human prostate cancer model.
Ko SC; Gotoh A; Thalmann GN; Zhau HE; Johnston DA; Zhang WW; Kao C; Chung LW
Hum Gene Ther; 1996 Sep; 7(14):1683-91. PubMed ID: 8886839
[TBL] [Abstract][Full Text] [Related]
4. Delivery of the p53 tumor suppressor gene into lung cancer cells by an adenovirus/DNA complex.
Nguyen DM; Wiehle SA; Koch PE; Branch C; Yen N; Roth JA; Cristiano RJ
Cancer Gene Ther; 1997; 4(3):191-8. PubMed ID: 9171938
[TBL] [Abstract][Full Text] [Related]
5. Suppression of distant pulmonary metastasis of MDA-MB 435 human breast carcinoma established in mammary fat pads of nude mice by retroviral-mediated TIMP-2 gene transfer.
Lee YK; So IS; Lee SC; Lee JH; Lee CW; Kim WM; Park MK; Lee ST; Park DY; Shin DY; Park CU; Kim YS
J Gene Med; 2005 Feb; 7(2):145-57. PubMed ID: 15546163
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic effect of a retroviral wild-type p53 expression vector in an orthotopic lung cancer model.
Fujiwara T; Cai DW; Georges RN; Mukhopadhyay T; Grimm EA; Roth JA
J Natl Cancer Inst; 1994 Oct; 86(19):1458-62. PubMed ID: 8089864
[TBL] [Abstract][Full Text] [Related]
7. Tumor suppression and therapy sensitization of localized and metastatic breast cancer by adenovirus p53.
Lebedeva S; Bagdasarova S; Tyler T; Mu X; Wilson DR; Gjerset RA
Hum Gene Ther; 2001 May; 12(7):763-72. PubMed ID: 11339893
[TBL] [Abstract][Full Text] [Related]
8. Systemic gene therapy with p53 reduces growth and metastases of a malignant human breast cancer in nude mice.
Lesoon-Wood LA; Kim WH; Kleinman HK; Weintraub BD; Mixson AJ
Hum Gene Ther; 1995 Apr; 6(4):395-405. PubMed ID: 7612697
[TBL] [Abstract][Full Text] [Related]
9. [Effects of exogenous wild type p53 on malignant growth of human lung cancer cell line].
Wang H; Lai B; Li J
Zhonghua Jie He He Hu Xi Za Zhi; 1998 May; 21(5):268-72. PubMed ID: 11326947
[TBL] [Abstract][Full Text] [Related]
10. High-efficiency gene transfer and high-level expression of wild-type p53 in human lung cancer cells mediated by recombinant adenovirus.
Zhang WW; Fang X; Mazur W; French BA; Georges RN; Roth JA
Cancer Gene Ther; 1994 Mar; 1(1):5-13. PubMed ID: 7621238
[TBL] [Abstract][Full Text] [Related]
11. A preclinical model of minimal residual cancer in the muscle highlights challenges associated with adenovirus-mediated p53 gene transfer.
Oakley R; Phillips E; Hooper R; Wilson D; Partridge M
Clin Cancer Res; 2002 Jun; 8(6):1984-94. PubMed ID: 12060644
[TBL] [Abstract][Full Text] [Related]
12. Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo.
Jacobs A; Tjuvajev JG; Dubrovin M; Akhurst T; Balatoni J; Beattie B; Joshi R; Finn R; Larson SM; Herrlinger U; Pechan PA; Chiocca EA; Breakefield XO; Blasberg RG
Cancer Res; 2001 Apr; 61(7):2983-95. PubMed ID: 11306477
[TBL] [Abstract][Full Text] [Related]
13. Recombinant adenovirus-p53 gene transfer and cell-specific growth suppression of human cervical cancer cells in vitro and in vivo.
Ahn WS; Bae SM; Lee KH; Lee JM; Namkoong SE; Chun HJ; Kim CK; Kim YW
Gynecol Oncol; 2004 Feb; 92(2):611-21. PubMed ID: 14766255
[TBL] [Abstract][Full Text] [Related]
14. In vivo transfer of bacterial marker genes results in differing levels of gene expression and tumor progression in immunocompetent and immunodeficient mice.
Lukacs KV; Porter CD; Pardo OE; Oakley RE; Steel RM; Judd DV; Browning JE; Geddes DM; Alton EW
Hum Gene Ther; 1999 Sep; 10(14):2373-9. PubMed ID: 10515457
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of p53 adenovirus-mediated gene therapy against human breast cancer xenografts.
Nielsen LL; Dell J; Maxwell E; Armstrong L; Maneval D; Catino JJ
Cancer Gene Ther; 1997; 4(2):129-38. PubMed ID: 9080122
[TBL] [Abstract][Full Text] [Related]
16. Retrovector encoding a green fluorescent protein-herpes simplex virus thymidine kinase fusion protein serves as a versatile suicide/reporter for cell and gene therapy applications.
Paquin A; Jaalouk DE; Galipeau J
Hum Gene Ther; 2001 Jan; 12(1):13-23. PubMed ID: 11177538
[TBL] [Abstract][Full Text] [Related]
17. Adenovirus-mediated p53 gene transfer suppresses growth of human glioblastoma cells in vitro and in vivo.
Köck H; Harris MP; Anderson SC; Machemer T; Hancock W; Sutjipto S; Wills KN; Gregory RJ; Shepard HM; Westphal M; Maneval DC
Int J Cancer; 1996 Sep; 67(6):808-15. PubMed ID: 8824552
[TBL] [Abstract][Full Text] [Related]
18. Adenovirus-mediated wild-type p53 overexpression inhibits endothelial cell differentiation in vitro and angiogenesis in vivo.
Riccioni T; Cirielli C; Wang X; Passaniti A; Capogrossi MC
Gene Ther; 1998 Jun; 5(6):747-54. PubMed ID: 9747454
[TBL] [Abstract][Full Text] [Related]
19. Transgene inheritance and retroviral infection contribute to the efficiency of gene expression in solid tumors inoculated with retroviral vector producer cells.
Tamiya T; Wei MX; Chase M; Ono Y; Lee F; Breakefield XO; Chiocca EA
Gene Ther; 1995 Oct; 2(8):531-8. PubMed ID: 8593603
[TBL] [Abstract][Full Text] [Related]
20. Tumor suppressor activity of RB and p53 genes in human breast carcinoma cells.
Wang NP; To H; Lee WH; Lee EY
Oncogene; 1993 Feb; 8(2):279-88. PubMed ID: 8426737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]